Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
XOMA RG (NQ: XOMA)
7.470 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, Aug 17, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 55,893
Open 7.380
Bid (Size) 7.070 (2000)
Ask (Size) 7.550 (100)
Prev. Close 7.470
Today's Range 7.380 - 7.540
52wk Range 3.960 - 8.130
Shares Outstanding 7,598,054
Dividend Yield N/A
Performance
YTD
+50.30%
+50.30%
1 Month
+4.48%
+4.48%
3 Month
+14.57%
+14.57%
6 Month
+45.05%
+45.05%
1 Year
+19.71%
+19.71%
Top News
More News
XOMA to Present New Growth Strategy at the 2017 Wedbush PacGrow Healthcare Conference
XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present the Company’s new strategic... Read More
from GlobeNewswire News Releases
XOMA Reports Second Quarter 2017 Financial Results
XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today announced its second quarter 2017 financial results and recent business highlights. Read More
from GlobeNewswire News Releases
More News
Read More
XOMA Earns $10 Million Milestone Payment as Another of its Licensed Assets Advances into Clinical Development
from GlobeNewswire News Releases
XOMA to Present New Strategic Initiatives at the UBS Global Healthcare Conference
from GlobeNewswire News Releases
XOMA Reports First Quarter 2017 Financial Results
from GlobeNewswire News Releases
Markets plunge over economic data
category Market News
from MarketMinute.com Market Updates
XOMA Announces Positive Results from its Phase 2 Proof-Of-Concept Study of Prolactin Inhibition
from GlobeNewswire News Releases
XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program
from GlobeNewswire News Releases
XOMA to Present Preclinical Data from its PTH1R Monoclonal Antibodies Program at the American Association for Cancer Research Annual Meeting
from GlobeNewswire News Releases
BRIEF-Xoma Q1 loss per share $2.37
category companyNews
from Reuters: Company News
12 Biggest Mid-Day Losers For Monday
category JCAP , BEBE , Intraday Update , and 16 more.
from Benzinga
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial

WHAT'S POPULAR IN THE VILLE

1
Does Your Neck Hurt Yet From The Metals Action?
2
Trouble Brewing For Johnson and Johnson
3
Reliq Health Technologies Is On The Fast Track To Profitability
4
Gold rallies after FED Minutes
5
Crude Oil is trying to hang below the critical support level